NX Prenatal Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
2ndary - Private
- Investors
-
10
NX Prenatal General Information
Description
Developer of diagnostic assays designed to detect, monitor, and manage pregnancy-related complications. The company's assays provide advanced isolation and enrichment of exosome and microvesicle particles from bodily fluids and detect biomarkers for prenatal risk assessment, enabling physicians to intervene in a timely manner and reduce the likelihood of preterm birth or minimize the complications that can arise for both the child and the mother.
Contact Information
Website
www.nxprenatal.comCorporate Office
- 4800 Fournace Place
- Suite BW28
- Bellaire, TX 77401
- United States
Corporate Office
- 4800 Fournace Place
- Suite BW28
- Bellaire, TX 77401
- United States
NX Prenatal Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 9. Later Stage VC (Series A3) | 21-Aug-2023 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 14-Oct-2022 | Completed | Generating Revenue | |||
| 7. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 6. Later Stage VC (Series A3) | 04-Aug-2021 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 20-Nov-2020 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 3. Debt - General | 20-Oct-2016 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A2) | 12-Feb-2016 | $25K | $775K | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A1) | 29-Jan-2014 | $750K | $750K | Completed | Product Development |
NX Prenatal Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A3 Prime | ||||||||
| Series A3 | ||||||||
| Series A2 | 454,545 | $0.000100 | 8% | $6.6 | $6.6 | 1x | $6.6 | 6.96% |
| Series A1 | 421,001 | $0.000100 | 8% | $6 | $6 | 1x | $6 | 6.45% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
NX Prenatal Comparisons
Industry
Financing
Details
NX Prenatal Competitors (3)
One of NX Prenatal’s 3 competitors is CirculoGene, a Venture Capital-Backed company based in Birmingham, AL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CirculoGene | Venture Capital-Backed | Birmingham, AL | ||||
| Modality Dx | Venture Capital-Backed | Hillsboro, OR | ||||
| BioGenex Laboratories | Corporation | Fremont, CA |
NX Prenatal Patents
NX Prenatal Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023150726-A2 | Three-tiered risk stratification for spontaneous preterm birth | Inactive | 03-Feb-2022 | ||
| WO-2023150726-A3 | Three-tiered risk stratification for spontaneous preterm birth | Inactive | 03-Feb-2022 | ||
| JP-2024546438-A | Methods for preparing and analyzing samples for biomarkers associated with placenta accreta | Pending | 11-Nov-2021 | ||
| EP-4430406-A2 | Methods of preparing and analyzing samples for biomarkers associated with placenta accreta | Pending | 11-Nov-2021 | ||
| EP-4430406-A4 | Methods of preparing and analyzing samples for biomarkers associated with placenta accreta | Pending | 11-Nov-2021 | G01N30/88 |
NX Prenatal Signals
NX Prenatal Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Johnson & Johnson Innovation - JLABS | Accelerator/Incubator | |||
| Angel (individual) | Minority | |||
| BlueTree Allied Angels | Angel Group | Minority | ||
| Angel (individual) | Minority | |||
| Golden Seeds | Venture Capital | Minority |
NX Prenatal FAQs
-
When was NX Prenatal founded?
NX Prenatal was founded in 2014.
-
Where is NX Prenatal headquartered?
NX Prenatal is headquartered in Bellaire, TX.
-
What is the size of NX Prenatal?
NX Prenatal has 9 total employees.
-
What industry is NX Prenatal in?
NX Prenatal’s primary industry is Biotechnology.
-
Is NX Prenatal a private or public company?
NX Prenatal is a Private company.
-
What is NX Prenatal’s current revenue?
The current revenue for NX Prenatal is .
-
How much funding has NX Prenatal raised over time?
NX Prenatal has raised $8.97M.
-
Who are NX Prenatal’s investors?
Johnson & Johnson Innovation - JLABS, , BlueTree Allied Angels, , and Golden Seeds are 5 of 10 investors who have invested in NX Prenatal.
-
Who are NX Prenatal’s competitors?
CirculoGene, Modality Dx, and BioGenex Laboratories are competitors of NX Prenatal.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process